Cargando…

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia

Graft-versus-host disease (GVHD) is a major cause of significant morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Invariant natural killer T (iNKT) cells are potent regulators of immune responses, protect from lethal GVHD, and promote graft-versus-leukemia effects i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmid, Hannes, Schneidawind, Corina, Jahnke, Simona, Kettemann, Felix, Secker, Kathy-Ann, Duerr-Stoerzer, Silke, Keppeler, Hildegard, Kanz, Lothar, Savage, Paul B., Schneidawind, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088196/ https://www.ncbi.nlm.nih.gov/pubmed/30127790 http://dx.doi.org/10.3389/fimmu.2018.01817

Ejemplares similares

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
por: Pecher, Ann-Christin, et al.
Publicado: (2019)

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells
por: Schmid, Hannes, et al.
Publicado: (2021)

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner
por: Jahnke, Simona, et al.
Publicado: (2019)

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
por: Secker, Kathy-Ann, et al.
Publicado: (2020)

Inhibition of effector B cells by ibrutinib in systemic sclerosis
por: Einhaus, Jakob, et al.
Publicado: (2020)

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations
por: Secker, Kathy-Ann, et al.
Publicado: (2020)

Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
por: Fitzel, Rahel, et al.
Publicado: (2023)

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
por: Fischer, Jacqueline, et al.
Publicado: (2023)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)

PB1803: SMAD1 IS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA WITH MLL REARRANGEMENT
por: Dietsche, Lisa, et al.
Publicado: (2023)

Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones
Publicado: (1993)

Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation
por: Ruan, Dan Fu, et al.
Publicado: (2023)

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
por: Van Elssen, Catharina, et al.
Publicado: (2020)

Predicting Alloreactivity in Transplantation
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

Alloreactivity-Based Medical Conditions
por: Vukmanovic, Stanislav, et al.
Publicado: (2013)

Metabolic Pathways in Alloreactive T Cells
por: Brown, Rebecca A., et al.
Publicado: (2020)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
por: Parisi, Sarah, et al.
Publicado: (2022)

On the nature of peptides involved in T cell alloreactivity
Publicado: (1991)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

Invariant Natural Killer T Cell Agonist Modulates Experimental Focal and Segmental Glomerulosclerosis
por: Pereira, Rafael L., et al.
Publicado: (2012)

Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
por: Sega, Emanuela I., et al.
Publicado: (2014)

SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression
por: Lin, Chiou-Hong, et al.
Publicado: (2018)

Geometric Analysis of Alloreactive HLA α-Helices
por: Ribarics, Reiner, et al.
Publicado: (2014)

Not all mismatches are equal: importance of alloreactivity direction
por: Perram, Jacinta, et al.
Publicado: (2021)

Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes
Publicado: (1993)

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
por: Fehm, Tanja, et al.
Publicado: (2007)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Contribution of direct and indirect recognition pathways to T cell alloreactivity
Publicado: (1993)

Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)
por: Smith, Pamela A., et al.
Publicado: (1997)

Mucins Help to Avoid Alloreactivity at the Maternal Fetal Interface
por: Redzovic, Arnela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_66psk6e3vhld174f5srb6o4n52